Exacerbation of autoimmune hemolytic anemia associated with pure red cell aplasia after COVID-19: A case report

Review Pathology

COVID-19 and Immune-Mediated RBC Destruction A Systematic Review

Jeremy W. Jacobs et al.

Summary: SARS-CoV-2 infection and vaccination can lead to autoimmune hemolytic anemia (AIHA), with various subtypes occurring approximately 7 days after infection symptoms and 5 days after vaccination.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2022)

Add to Collection

Article Infectious Diseases

Pure red cell aplasia accompanied by COVID-19 successfully treated using cyclosporine

Susumu Yamazaki et al.

Summary: A case report of a severe COVID-19 patient with pure red cell aplasia was presented, and successful treatment was achieved using cyclosporine.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Case Report: Pulmonary Tuberculosis Accompanied by Pure Red Cell Aplasia and Autoimmune Hemolytic Anemia

Hayato Shimizu et al.

Summary: This article describes a rare case of pulmonary tuberculosis accompanied by pure red cell aplasia and autoimmune hemolytic anemia. The hematologic disorders improved with treatment of the tuberculosis, suggesting that tuberculosis should be considered as a possible cause of pure red cell aplasia.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2022)

Add to Collection

Letter Hematology

A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS-CoV-2 vaccine

Tomas M. Murdych

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2022)

Add to Collection

Letter Hematology

SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia

Nicholas C. J. Lee et al.

BLOOD ADVANCES (2022)

Add to Collection

Article Medicine, General & Internal

Acquired pure red cell aplasia after severe acute respiratory syndrome corona virus 2 infection: a case report

Imane Karrat et al.

Summary: This case study investigates a 77-year-old male who developed severe anemia 8 weeks after contracting COVID-19. The patient was diagnosed with acquired pure red cell aplasia, with no underlying disorder found. Treatment with corticosteroids resulted in a positive response. The findings suggest that COVID-19 may have delayed complications such as acquired pure red cell aplasia.

JOURNAL OF MEDICAL CASE REPORTS (2022)

Add to Collection

Article Infectious Diseases

Warm Autoimmune Hemolytic Anemia and Pure Red Cell Aplasia during a Severe COVID-19 B.1.1.7 Infection

Anukul Ghimire et al.

Summary: This case report presents a rare complication of COVID-19 infection, warm autoimmune hemolytic anemia (AIHA), in a patient who also had concurrent pure red cell aplasia caused by parvovirus B19 infection.

INFECTIOUS DISEASE REPORTS (2022)

Add to Collection

Article Hematology

COVID-19 associated with severe autoimmune hemolytic anemia

Jeremy Jacobs et al.

Summary: The potential association between autoimmune hemolytic anemia (AIHA) and COVID-19 is unclear and requires further research. This article discusses rare cases of AIHA in the setting of COVID-19, emphasizing the importance of laboratory testing and treatment for severe AIHA patients without other underlying conditions.

TRANSFUSION (2021)

Add to Collection

Review Hematology

Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases

Erfan Taherifard et al.

Summary: This study systematically reviewed hematologic autoimmune complications in COVID-19 patients, revealing immune thrombocytopenic purpura as the most common disorder followed by autoimmune hemolytic anemia. The findings suggest the need to consider autoimmune etiology and individualized treatment strategies for patients experiencing abnormal hematologic changes during the course of COVID-19 infection.

HEMATOLOGY (2021)

Add to Collection

Article Medicine, General & Internal